Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Kyphoscoliosis Treatment Market?

The market size for kyphoscoliosis treatment has witnessed robust growth in the previous years. From $3.08 billion in 2024, it is projected to expand to $3.27 billion in 2025, representing a compound annual growth rate (CAGR) of 6.3%. The historical growth can be credited to the development in regenerative medicine, contributions from genetic research, the emergence of telemedicine and remote monitoring, and improvements in rehabilitation programs.

What Growth Rate Is Forecasted for the Kyphoscoliosis Treatment Market by 2029?

Expectations are high for substantial growth in the kyphoscoliosis treatment market in the coming years, with a projected value of $4.1 billion by 2029, representing a compound annual growth rate (CAGR) of 5.8%. Factors that are expected to contribute to this growth during the forecast period include the adoption of personalized treatment strategies, advancements in biomechanical research, the use of remote monitoring and telehealth services, and ongoing genetic research. The period is also expected to see trends such as the application of advanced surgical procedures, innovative bracing technologies, personalized treatment plans, the use of 3D printing technology, and innovations in pain management.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13292&type=smp

Which Key Companies Are Shaping the Future of the Kyphoscoliosis Treatment Market?

Major companies operating in the kyphoscoliosis treatment market report are Johnson & Johnson Services Inc., Aspen Medical Products LLC, Medtronic PLC, Stryker Corporation, Milwaukee Brace Company, Zimmer Biomet Holdings Inc., Perrigo Company PLC, Teva Pharmaceuticals Inc., B. Braun Melsungen Aktiengesellschaft, Aurobindo Pharma Limited, Integra LifeSciences Ltd., NuVasive Inc., DJO Global Inc., Globus Medical Inc., Boston Orthotics & Prosthetics, Ossur hf., Aesculap Inc., DeRoyal Industries Inc., MicroPort Scientific Corp., Alphatec Holdings Inc., Trulife Ltd., Ottobock SE & Co. KGaA, Orthofix Holdings Inc., OrthoPediatrics Corp., Proteor S.A., Orthomerica Products Inc., Breg Inc., Innomed Inc., Restorative Care of America Inc., Spinal Elements Inc.

Which Factors Are Driving Demand in the Kyphoscoliosis Treatment Industry?

A surge in spinal cord injuries is anticipated to boost the kyphoscoliosis treatment market. Spinal cord injuries refer to any trauma or damage to the spine’s structures such as the vertebrae, intervertebral discs, ligaments, muscles, nerves, and other supporting structures, causing kyphoscoliosis and subsequent changes in spinal alignment. Comprehensive treatment involving orthopedic evaluation, physical therapy, bracing, possible surgery, pain management, and a multidisciplinary healthcare team dedicated to patient education and personal care plans are implemented for kyphoscoliosis resulting from spinal cord injuries. For example, the Alabama Department of Public Health reported 3,817 neurological injuries involving the head and spinal cord in 2022, a decrease from 4,734 cases in 2021. Thus, the escalating number of spinal cord injuries fuels the kyphoscoliosis treatment market’s growth. The kyphoscoliosis treatment market is set to benefit from the rise in telemedicine usage. Telemedicine, a healthcare sector utilizing telecommunications technology such as videoconferencing, phone calls, and digital messaging to provide clinical services remotely, facilitates consultation with orthopedic specialists and spine surgeons for patients who may find it challenging to travel to a healthcare facility due to physical restrictions stemming from kyphoscoliosis. For example, a 2022 survey by Rock Health, a US-based non-profit corporation, showed that 80% of respondents had used telemedicine at some point in their lives, an 8 percentage point increase from 72% in 2021. Hence, telemedicine contributes to the advancement of the healthcare transportation service market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13292&type=smp

How Is the Kyphoscoliosis Treatment Market Segmented by Several Divisions?

The kyphoscoliosis treatment market covered in this report is segmented –

1) By Type: Postural Kyphosis, Scheuermann’s Kyphosis, Congenital Kyphosis

2) By Treatment: Medications, Surgery And Bracing

3) By End-User: Hospital, Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Postural Kyphosis: Adolescent Postural Kyphosis, Adult Postural Kyphosis

2) By Scheuermann’s Kyphosis: Adolescent Scheuermann’s Kyphosis, Adult Scheuermann’s Kyphosis

3) By Congenital Kyphosis: Type I Congenital Kyphosis, Type II Congenital Kyphosis, Other Congenital Forms

What are the Emerging Market Trends Driving the Growth of the Kyphoscoliosis Treatment Industry?

In the kyphoscoliosis treatment market, leading firms are progressing with the development of novel products like the MARVEL growing rod system, specifically purposed for early onset scoliosis. This system, which is a posterior stabilizing rod, could be implanted surgically and its extension could be periodically manipulated with manual mechanical actuation. For instance, Globus Medical Inc., an American medical device firm, launched the MARVEL Growing Rod System in July 2023. This system is designed to facilitate patients below 10 years of age with early-onset scoliosis to obtain and maintain correction, while allowing continuous growth using minimally invasive distraction. It provides significant diversion along with immediate tactile response and automated locking, thus ensuring reliable growth. One such pioneering product is the Growing Rod System, which is predicted to assist in the impending growth of the industry.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/kyphoscoliosis-treatment-global-market-report

Which Regions Are Driving Growth in the Kyphoscoliosis Treatment Market?

North America was the largest region in the kyphoscoliosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kyphoscoliosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13292

This Report Delivers Insight On:

1. How big is the kyphoscoliosis treatment market, and how is it changing globally?

2. Who are the major companies in the kyphoscoliosis treatment market, and how are they performing?

3. What are the key opportunities and risks in the kyphoscoliosis treatment market right now?

4. Which products or customer segments are growing the most in the kyphoscoliosis treatment market?

5. What factors are helping or slowing down the growth of the kyphoscoliosis treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model